The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers.
Publication/Presentation Date
1-1-2017
Abstract
There are challenges to conducting rare cancer clinical trials due to issues surrounding clinical trial design, patient recruitment, and analysis of the study outcomes. This article highlights the challenges of research and data analysis in rare cancers and proposes future study directions using less traditional approaches.
Volume
8
Issue
4
First Page
388
Last Page
391
ISSN
2150-0878
Published In/Presented At
Grande, C., Visovsky, C., & Brose, M. S. (2017). The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers. Journal of the advanced practitioner in oncology, 8(4), 388–391.
Disciplines
Medicine and Health Sciences
PubMedID
30018844
Department(s)
Hematology-Medical Oncology Division
Document Type
Article
COinS